Vascular hyporesponsiveness to vasodilators in rats with cirrhosis

Journal of Hepatology

Volumn 26, Issue 2, 1997, Pages 382-386

  Safka, Vaclav ^a   Moreau, Richard ^a   Gadano, Adrián ^a   Lebrec, Didier ^a  

^a Lab d'Hemodynamique Splanchnique   (France)

Author keywords

portal hypertension; vasorelaxation

Indexed keywords

APRIKALIM; DILTIAZEM; NICARDIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; VASODILATOR AGENT; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; DOSE RESPONSE; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0031039606     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80056-6     Document Type: Article

References (22)

1. Moreau R, Lebrec D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol. 22:1995;370-376.
2. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328-338.
3. Ferraz JGP, McKnight W, Sharkey KA, Wallace JL. Impaired vasodilatory responses in the gastric microcirculation of anesthesized rats with secondary biliary cirrhosis. Gastroenterology. 108:1995;1183-1191.
4. Harrisson DG, Bates JN. The nitrovasodilators. New ideas about old drugs. Circulation. 87:1993;1461-1467.
5. Moreau R, Komeichi H, Kirstetter P, Ohsuga M, Cailmail S, Lebrec D. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gastroenterology. 106:1994;1016-1023.
6. Spedding M, Paoletti R. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev. 44:1992;363-376.
7. Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol. 251:1986;G176-G180.
8. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 65:1984;305-311.
9. Hartleb M, Moreau R, Gaudin C, Lebrec D. Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis. J Hepatol. 22:1995;202-207.
10. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
11. Moreau R, Lebrec D. Nitrovasodilators and portal hypertension. J Hepatol. 10:1990;263-267.
12. Michielsen PP, Boeckxstaens GE, Sys SU, Herman AG, Pelckmans PA. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats. Eur J Pharmacol. 273:1995;67-74.
13. Caimail S, Moreau R, Gadano A, Tazi KA, Lebrec D. The role of calcium channels in in vitro vascular hyporeactivity to endothelin-1 (ET-1) in rats with cirrhosis. Hepatology. 22:1995;258A.
14. Mathie RT, Ralevic V, Moore KP, Burnstock G. Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxide? Hepatology. 23:1996;130-136.
15. Albillos A, Rossi I, Cacho G, Martinez MV, Millan I, Abreu L, Barrios C, Escartin P. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Pathol. 268:1995;G459-G464.
16. Claria J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, Rodès J. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology. 20:1994;1615-1621.
17. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extra- or intra-hepatic portal hypertension. Hepatology. 18:1993;621-627.
18. Cahill PA, Wu Y, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest. 93:1994;2691-2700.
19. Koshy A, Hadengue A, Lee SS, Jiron MI, Lebrec D. Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis. Clin Pharmacol Ther. 42:1987;295-298.
20. Navasa M, Bosch J, Reichen J, Bru C, Mastai R, Zysset T, Silva G, Chesta J, Rodès J. Effect of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension. Hepatology. 8:1988;850-854.
21. Avagnina P, Sansoé G, Martini M, Peretti P, Tinivella M, Molino G. Effects of nifedipine on functional liver plasma flow in normal subjects and in patients with cirrhosis. Clin Pharmacol Ther. 53:1993;368-373.
22. Ota K, Shijo H, Kokawa H, Kubara K, Kim T, Akiyoshi N, Yokoyama M, Okumura M. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis. J Gastroenterol Hepatol. 10:1995;198-204.